PDE / ADE · OEL / OEB

Home→PDE/ADE · OEL/OEB Profiles → Methyl Aminolevulinate→

Methyl Aminolevulinate PDE report and OEL report profile

Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.

CAS Registry Number
33320-16-0
Molecular formula
C6H11NO3
Molecular weight
145.16 g/mol
Drug class
Topical photosensitiserprodrug for photodynamic therapy
Mechanism of action
Methyl aminolevulinate is converted intracellularly to photoactive porphyrins, including protoporphyrin IX, which accumulate in treated skin lesions. After illumination with light of an appropriate wavelength in the presence of oxygen, these porphyrins generate singlet oxygen and other reactive oxygen species, causing phototoxic damage to target cells.
Indications / reported uses
  • Photodynamic treatment of actinic keratoses.
  • Photodynamic treatment of selected superficial basal cell carcinomas and Bowen’s disease, according to the authorised product label and illumination protocol.

Sources: https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=d02af310-d097-4886-86e5-adcf6bca0533 · https://www.medicines.org.uk/emc/product/6777/smpc · https://register.awmf.org/assets/guidelines/032_D_Krebsgesellschaft/032-022OLeng_S3_Actinic-keratosis-and-squamous-cell-carcinoma-of-the-skin_2023-07.pdf · DailyMed

View request basketPrefer email? info@toxwriter.com
PDE / ADE derivationOEL derivationOEB / OHC banding
Assessment scope

PDE/ADE and OEL/OEB assessment

ToxWriter provides project-specific support for Methyl Aminolevulinate PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Methyl Aminolevulinate Permitted Daily Exposure (PDE) report (the Methyl Aminolevulinate PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Methyl Aminolevulinate Occupational Exposure Limit (OEL) report (the Methyl Aminolevulinate OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.

Assessment may cover

  • PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
  • OEL derivation considering relevant hazards, exposure route, duration and workplace conditions.
  • OEB/OHC banding where requested and supported by the evidence; an exposure band is not a numerical OEL.
  • Review of substance identity, evidence quality, uncertainty and data gaps.
PDE/ADE, OEL & OEB/OHC regulatory framework

The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.